Prescription and Dispensing Requirements
Statutory Text (3 Articles)
L.N. 401 of 2014
MEDICINES ACT
(CAP. 458)
Prescription and Dispensing Requirements
(Amendment) Rules, 2014
IN exercise of the powers conferred by article 106 of the
Medicines Act, the Minister for Energy and Health, after consultation
with the Licensing Authority, has made the following regulations:-
The title of these regulations is the Prescription and Citation.
Dispensing Requirements (Amendment) Rules, 2014, and these rules
shall be read and construed as one with the Prescription and S.L. 458.49
Dispensing Requirements Rules, hereinafter referred to as "the
principal rules".
Rule 3 of the principal rules shall be amended as follows
Amends rule 3
of the principal
rules.
(a)
in paragraph (b) thereof, for the words "the full
name, and contact details" there shall be substituted the words
"the full name, professional qualification, work address
(including the name of the relevant Member State) and contact
details (e-mail and telephone or fax, the latter both with
international prefix)";
(b)
paragraph (c) thereof shall be substituted by the
following
"(c) bear the name, date of birth, age and locality
of current residence of the patient and the 'Common
name' as defined in article 2 of the Medicines Act; the
brand name if (i) the prescribed product is a biological
medicinal product, as defined in Part I, point 3.2.1.1. of the
Schedule to the Medicines (Marketing Authorisation)
Regulations, or (ii) if the person authorised in accordance
with article 81 of the Medicines Act to issue a prescription
deems it medically necessary; in that case the prescription
shall shortly state the reasons justifying the use of the
brand name; the strength, dosage form, quantity and
duration of treatment of each prescribed product included
in the said prescription, together with clear instructions on
how the prescribed product is to be taken or used. Repeat
prescriptions are to be marked accordingly indicating the
total period of duration of treatment;";
(c)
in paragraph (d) thereof, for the words "which may
include digital signatures." there shall be substituted the words
"which may include digital signatures; and";
(d)
immediately after paragraph (d) thereof, there shall
be added the following new paragraph
"(e) if the product prescribed qualifies under the
criteria for prescribing a brand name as specified in
paragraph (c), the pharmacist dispensing the product shall
dispense the product with the brand name as prescribed.".
€0.18